Global Registry: ExAblate Neuro MR Guided Focused Ultrasound (MRgFUS) of Neurological Disorders:

Running, not enrolling

Conditions studied: Essential Tremor, Parkinson's Disease, Movement Disorders, Neuropathic Pain

In brief

A global post approval study to collect safety and effectiveness data related to ExAblate Neuro for the treatment of certain disorders such as Essential Tremor, Parkinson's Movement Disorders, or Neuropathic Pain within the thalamus and/or pallidum.

Key facts

Study ID

NCT03100474

Run by

InSightec

People needed

500

Starts

2016-12-01

Expected to finish

2026-06-01

Last updated by the study team

2025-05-02

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meets labeling indication for use per information for prescribers
• Target is accessible by Focused Ultrasound per treatment planning parameters

You may not qualify if…

• Do not agree to participate or who are unlikely to participate over an extended period of time

Where it is running

• Stanford University — Stanford, California, United States
• University of Maryland — Baltimore, Maryland, United States
• University of Pennsylvania — Philadelphia, Pennsylvania, United States
• University of Virginia — Charlottesville, Virginia, United States
• Swedish Neuroscience Institute — Seattle, Washington, United States
• Sunnybrook — Toronto, Ontario, Canada
• Rambam Healthcare Campus — Haifa, Israel
• Sheba Medical Center — Ramat Gan, Israel
• Chang Bing Show Chwan Memorial Hospital — Chang-hua, Taiwan

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.